Abbott Laboratories (ABT) Equity Ratio (2009 - 2026)

Abbott Laboratories has disclosed Equity Ratio across 18 years of filings, most recently posting 0.47 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.47, down 19.53% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.47 (down 19.53% YoY), and the FY2025 annual result was 0.61, up 23493.42% from the prior year.
• Equity Ratio came in at 0.47 for Q1 2026 at Abbott Laboratories, down from 0.61 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 8.57 in Q4 2022 to a low of 0.2 in Q3 2022.
• The 5-year median for Equity Ratio is 0.0 (2024), against an average of 0.66.
• Across the five-year window, Equity Ratio plunged 10305.32% in 2023 and surged 188770.15% in 2025, its largest moves.
• Abbott Laboratories' Equity Ratio stood at 8.57 in 2022, then slumped by 99.99% to 0.0 in 2023, then jumped by 360.61% to 0.0 in 2024, then surged by 23493.42% to 0.61 in 2025, then decreased by 22.53% to 0.47 in 2026.
• The last three Equity Ratio figures came in at 0.47 (Q1 2026), 0.61 (Q4 2025), and 0.61 (Q3 2025), per Business Quant data.